Protein,Protein_definition,Disease_category,Disease,Method,Nb_SNP,OR[95%CI],P_value
NEFL,Neurofilament light polypeptide,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",Inverse variance weighted,6,1.11 [0.62-1.96],0.728927177291279
NEFL,Neurofilament light polypeptide,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,Inverse variance weighted,6,1.05 [0.90-1.23],0.504609277370391
NEFL,Neurofilament light polypeptide,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,Inverse variance weighted,6,1.08 [0.93-1.25],0.310988611050336
NEFL,Neurofilament light polypeptide,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,Inverse variance weighted,6,1.29 [0.21-7.83],0.782798300012404
NEFL,Neurofilament light polypeptide,Chapter I Certain infectious and parasitic diseases,Other septicaemia,Inverse variance weighted,6,1.09 [0.83-1.42],0.541846102263902
NEFL,Neurofilament light polypeptide,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,Inverse variance weighted,6,2.69 [0.17-41.63],0.479507109696291
NEFL,Neurofilament light polypeptide,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",Inverse variance weighted,6,1.07 [0.84-1.37],0.58195198940419
NEFL,Neurofilament light polypeptide,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",Inverse variance weighted,6,0.89 [0.69-1.14],0.351654394367841
NEFL,Neurofilament light polypeptide,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",Inverse variance weighted,6,1.10 [0.42-2.86],0.851755477201482
NEFL,Neurofilament light polypeptide,Chapter X Diseases of the respiratory system,Early onset COPD,Inverse variance weighted,6,0.78 [0.50-1.22],0.282585253776055
NEFL,Neurofilament light polypeptide,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,Inverse variance weighted,6,1.11 [0.66-1.85],0.701081046106654
NEFL,Neurofilament light polypeptide,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,Inverse variance weighted,6,0.87 [0.65-1.17],0.362502525335451
NEFL,Neurofilament light polypeptide,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,Inverse variance weighted,6,0.83 [0.64-1.08],0.159994744862624
NEFL,Neurofilament light polypeptide,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",Inverse variance weighted,6,0.87 [0.48-1.58],0.650141803854308
NEFL,Neurofilament light polypeptide,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,Inverse variance weighted,6,0.88 [0.69-1.12],0.306291896340484
NEFL,Neurofilament light polypeptide,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",Inverse variance weighted,6,1.01 [0.74-1.36],0.966297132019347
NEFL,Neurofilament light polypeptide,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,Inverse variance weighted,6,1.12 [0.88-1.43],0.353192014600588
NEFL,Neurofilament light polypeptide,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",Inverse variance weighted,6,1.08 [0.79-1.47],0.640415608724735
NEFL,Neurofilament light polypeptide,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,Inverse variance weighted,6,1.11 [0.90-1.36],0.334779450584079
NEFL,Neurofilament light polypeptide,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,Inverse variance weighted,6,1.10 [0.95-1.26],0.199903689546771
NEFL,Neurofilament light polypeptide,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,Inverse variance weighted,6,0.88 [0.40-1.91],0.742317718501294
NEFL,Neurofilament light polypeptide,Chapter V Mental and behavioural disorders,Depression,Inverse variance weighted,6,0.95 [0.80-1.13],0.581849430703634
NEFL,Neurofilament light polypeptide,Chapter V Mental and behavioural disorders,Depression or dysthymia,Inverse variance weighted,6,0.97 [0.83-1.12],0.670002871747874
NEFL,Neurofilament light polypeptide,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,Inverse variance weighted,6,0.70 [0.38-1.32],0.271392566743342
NEFL,Neurofilament light polypeptide,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,Inverse variance weighted,6,1.08 [0.90-1.30],0.409262988784268
NEFL,Neurofilament light polypeptide,Chapter VI Diseases of the nervous system,Epilepsy,Inverse variance weighted,6,0.91 [0.69-1.20],0.497875594594499
NEFL,Neurofilament light polypeptide,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,Inverse variance weighted,6,0.60 [0.22-1.68],0.331341960378794
NEFL,Neurofilament light polypeptide,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",Inverse variance weighted,6,1.14 [0.95-1.37],0.156171695166051
NEFL,Neurofilament light polypeptide,Chapter VI Diseases of the nervous system,Other neurological diseases,Inverse variance weighted,6,1.04 [0.86-1.26],0.653996616045804
NEFL,Neurofilament light polypeptide,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,Inverse variance weighted,6,1.24 [0.91-1.70],0.16431602330583
NEFL,Neurofilament light polypeptide,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,Inverse variance weighted,6,1.15 [0.97-1.37],0.105810298921222
NEFL,Neurofilament light polypeptide,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,Inverse variance weighted,6,1.13 [0.93-1.38],0.226008998895314
NEFL,Neurofilament light polypeptide,Chapter IX Diseases of the circulatory system,Angina pectoris,Inverse variance weighted,6,1.11 [0.72-1.72],0.623802175717908
NEFL,Neurofilament light polypeptide,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,Inverse variance weighted,6,1.02 [0.57-1.83],0.948985177348842
NEFL,Neurofilament light polypeptide,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,Inverse variance weighted,6,1.14 [0.72-1.80],0.566450179354031
NEFL,Neurofilament light polypeptide,Chapter IX Diseases of the circulatory system,Conduction disorders,Inverse variance weighted,6,0.97 [0.51-1.84],0.921970768835797
NEFL,Neurofilament light polypeptide,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,Inverse variance weighted,6,1.22 [0.81-1.85],0.339643101580294
NEFL,Neurofilament light polypeptide,Chapter IX Diseases of the circulatory system,"Heart failure, strict",Inverse variance weighted,6,1.19 [0.91-1.56],0.210650352073467
NEFL,Neurofilament light polypeptide,Chapter IX Diseases of the circulatory system,"Hypertension, essential",Inverse variance weighted,6,1.35 [1.07-1.70],0.0108879838216636
NEFL,Neurofilament light polypeptide,Chapter IX Diseases of the circulatory system,Hypertension,Inverse variance weighted,6,1.38 [1.07-1.78],0.0142327032739675
NEFL,Neurofilament light polypeptide,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",Inverse variance weighted,6,2.95 [0.25-35.37],0.393764921903783
NEFL,Neurofilament light polypeptide,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,Inverse variance weighted,6,1.33 [0.49-3.64],0.576534308847641
NEFL,Neurofilament light polypeptide,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",Inverse variance weighted,6,1.15 [0.83-1.59],0.394174424426537
NEFL,Neurofilament light polypeptide,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,Inverse variance weighted,6,1.05 [0.74-1.49],0.798348814469546
NEFL,Neurofilament light polypeptide,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",Inverse variance weighted,6,1.10 [0.65-1.88],0.724161626921167
NEFL,Neurofilament light polypeptide,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,Inverse variance weighted,6,1.67 [0.79-3.52],0.180466331703241
NEFL,Neurofilament light polypeptide,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,Inverse variance weighted,6,1.49 [0.80-2.76],0.207279019985194
NEFL,Neurofilament light polypeptide,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,Inverse variance weighted,6,1.08 [0.79-1.47],0.64577734353032
NEFL,Neurofilament light polypeptide,Chapter IX Diseases of the circulatory system,DVT of lower extremities,Inverse variance weighted,6,1.25 [0.91-1.70],0.161562319412202
NEFL,Neurofilament light polypeptide,Chapter IX Diseases of the circulatory system,Pulmonary embolism,Inverse variance weighted,6,0.87 [0.61-1.23],0.422132254312204
NEFL,Neurofilament light polypeptide,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",Inverse variance weighted,6,1.11 [0.91-1.36],0.300134441733673
NEFL,Neurofilament light polypeptide,Chapter IX Diseases of the circulatory system,Transient ischemic attack,Inverse variance weighted,6,1.18 [0.94-1.48],0.15592557767531
NEFL,Neurofilament light polypeptide,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,Inverse variance weighted,6,0.91 [0.52-1.57],0.721829505083176
NEFL,Neurofilament light polypeptide,Chapter IX Diseases of the circulatory system,Venous thromboembolism,Inverse variance weighted,6,1.03 [0.83-1.28],0.765241769229623
NEFL,Neurofilament light polypeptide,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,Inverse variance weighted,6,0.96 [0.62-1.49],0.856094747918054
NEFL,Neurofilament light polypeptide,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",Inverse variance weighted,6,1.02 [0.87-1.20],0.785541516333819
NEFL,Neurofilament light polypeptide,Chapter X Diseases of the respiratory system,Influenza and pneumonia,Inverse variance weighted,6,0.98 [0.86-1.12],0.800889568768971
NEFL,Neurofilament light polypeptide,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,Inverse variance weighted,6,1.02 [0.88-1.17],0.820844795956279
NEFL,Neurofilament light polypeptide,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,Inverse variance weighted,6,1.04 [0.84-1.29],0.726689844710272
NEFL,Neurofilament light polypeptide,Chapter X Diseases of the respiratory system,Other diseases of pleura,Inverse variance weighted,6,1.19 [0.82-1.71],0.362527695293734
NEFL,Neurofilament light polypeptide,Chapter X Diseases of the respiratory system,Pleural effusion,Inverse variance weighted,6,1.25 [0.75-2.09],0.38946774417917
NEFL,Neurofilament light polypeptide,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,Inverse variance weighted,6,1.02 [0.81-1.28],0.84648124828292
NEFL,Neurofilament light polypeptide,Chapter XI Diseases of the digestive system,Other diseases of intestines,Inverse variance weighted,6,0.96 [0.82-1.12],0.569681663212259
NEFL,Neurofilament light polypeptide,Chapter XI Diseases of the digestive system,Diseases of liver,Inverse variance weighted,6,1.06 [0.61-1.86],0.830791951455404
NEFL,Neurofilament light polypeptide,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",Inverse variance weighted,6,1.09 [0.91-1.29],0.347379321674957
NEFL,Neurofilament light polypeptide,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,Inverse variance weighted,6,1.06 [0.75-1.49],0.749145342543763
NEFL,Neurofilament light polypeptide,Chapter V Mental and behavioural disorders,Any mental disorder,Inverse variance weighted,6,1.04 [0.88-1.24],0.614123242327104
NEFL,Neurofilament light polypeptide,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,Inverse variance weighted,6,1.16 [0.69-1.95],0.564129963417829
NEFL,Neurofilament light polypeptide,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,Inverse variance weighted,6,1.27 [1.03-1.56],0.0240495176325381
NEFL,Neurofilament light polypeptide,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,Inverse variance weighted,6,1.08 [0.59-2.00],0.798296213938562
NEFL,Neurofilament light polypeptide,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,Inverse variance weighted,6,0.99 [0.89-1.10],0.8578626699041
NEFL,Neurofilament light polypeptide,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,Inverse variance weighted,6,0.99 [0.86-1.13],0.856558691101976
NEFL,Neurofilament light polypeptide,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,Inverse variance weighted,6,1.08 [0.87-1.34],0.494795046604827
NEFL,Neurofilament light polypeptide,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,Inverse variance weighted,6,1.10 [0.94-1.29],0.21649712941262
NEFL,Neurofilament light polypeptide,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",Inverse variance weighted,6,1.08 [0.90-1.30],0.387179649224792
NEFL,Neurofilament light polypeptide,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,Inverse variance weighted,6,1.13 [0.83-1.55],0.440728413979746
NEFL,Neurofilament light polypeptide,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,Inverse variance weighted,6,1.01 [0.82-1.26],0.915460830817361
NEFL,Neurofilament light polypeptide,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,Inverse variance weighted,6,0.87 [0.66-1.14],0.309558286346456
NEFL,Neurofilament light polypeptide,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,Inverse variance weighted,6,1.22 [1.03-1.43],0.0193344379167406
NEFL,Neurofilament light polypeptide,Chapter XIV Diseases of the genitourinary system,Acute renal failure,Inverse variance weighted,6,0.87 [0.58-1.32],0.510275707625341
NEFL,Neurofilament light polypeptide,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,Inverse variance weighted,6,1.02 [0.75-1.40],0.896617373373879
NEFL,Neurofilament light polypeptide,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,Inverse variance weighted,6,0.98 [0.60-1.60],0.928868491144202
NEFL,Neurofilament light polypeptide,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,Inverse variance weighted,6,0.72 [0.37-1.40],0.339216135188862
NEFL,Neurofilament light polypeptide,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,Inverse variance weighted,6,0.96 [0.79-1.16],0.650442795744928
NEFL,Neurofilament light polypeptide,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,Inverse variance weighted,6,1.51 [0.85-2.68],0.164601783485268
NEFL,Neurofilament light polypeptide,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,Inverse variance weighted,6,1.03 [0.84-1.28],0.757890509734925
NEFL,Neurofilament light polypeptide,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,Inverse variance weighted,6,1.05 [0.91-1.21],0.519332547926126
NEFL,Neurofilament light polypeptide,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,Inverse variance weighted,6,0.91 [0.60-1.37],0.656772907018544
NEFL,Neurofilament light polypeptide,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,Inverse variance weighted,6,1.01 [0.62-1.63],0.972033726520749
NEFL,Neurofilament light polypeptide,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",Inverse variance weighted,6,1.09 [0.75-1.58],0.669962237052743
